financetom
Business
financetom
/
Business
/
Trump Reportedly Tells Fox Business Mexico, Canada Tariffs 'Could Go Up' Over Time
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Trump Reportedly Tells Fox Business Mexico, Canada Tariffs 'Could Go Up' Over Time
Mar 7, 2025 5:14 AM

07:42 AM EST, 03/07/2025 (MT Newswires) -- US tariffs on Canada and Mexico "could go up" over time, exceeding the 25% rate enacted earlier in the week, multiple media outlets reported Friday, citing President Donald Trump's Fox Business interview.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Enlivex Therapeutics Gets Regulatory Nod in Israel to Begin Phase I Trial for Potential Psoriatic Arthritis Treatment
Enlivex Therapeutics Gets Regulatory Nod in Israel to Begin Phase I Trial for Potential Psoriatic Arthritis Treatment
Jul 23, 2024
09:53 AM EDT, 07/23/2024 (MT Newswires) -- Enlivex Therapeutics ( ENLV ) said Tuesday it has received authorization from the Israeli Ministry of Health to start a phase I clinical trial to assess the safety and tolerability of Allocetra after injection into an affected joint in psoriatic arthritis patients. The company said measuring the frequency and severity of adverse events...
FTC Seeking Info From JPMorgan, Mastercard on 'Surveillance Pricing'
FTC Seeking Info From JPMorgan, Mastercard on 'Surveillance Pricing'
Jul 23, 2024
09:48 AM EDT, 07/23/2024 (MT Newswires) -- The US Federal Trade Commission said Tuesday it issued orders to JPMorgan Chase ( JPM ) , Mastercard ( MA ) , Accenture ( ACN ) and five other companies that offer surveillance pricing products and services that incorporate data about consumers' characteristics and behavior. The orders seek information about the potential impact...
Arcutis Biotherapeutics Submits Supplemental New Drug Application to US FDA for Psoriasis Treatment
Arcutis Biotherapeutics Submits Supplemental New Drug Application to US FDA for Psoriasis Treatment
Jul 23, 2024
09:48 AM EDT, 07/23/2024 (MT Newswires) -- Arcutis Biotherapeutics ( ARQT ) said Tuesday that it has submitted a supplemental new drug application to the US Food and Drug Administration for Zoryve foam 0.3% to treat adults and adolescents aged 12 and above with scalp and body psoriasis. The submission is backed by positive results from a late-stage trial, a...
Kimberly-Clark raises annual profit forecast on higher prices
Kimberly-Clark raises annual profit forecast on higher prices
Jul 23, 2024
July 23 (Reuters) - Kleenex tissue maker Kimberly-Clark ( KMB ) on Tuesday raised its forecast for full-year profit after beating Wall Street estimates for second-quarter earnings, betting on higher prices and steady demand for its personal care products. Demand for Kimberly-Clark's ( KMB ) products such as skin health and hygiene held steady, on the back of double-digit volume...
Copyright 2023-2026 - www.financetom.com All Rights Reserved